Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DX25F5ZVB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $49,449
Award facts
- Contract value 100% obligated
- $49,449.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $49,449.30 for the supply of Entyvio 300 mg vials. The award, issued on April 21, 2025, with an ultimate completion date of May 12, 2025, carries no set-aside designation and represents a direct distribution of this specialized pharmaceutical product to support military healthcare facilities. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million agreement valid through November 2026 that enables the issuance of firm fixed-price orders for comprehensive pharmaceutical supply needs across the Defense Department's healthcare system.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to maintain a robust portfolio of delivery orders from the DLA. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. This particular award for Entyvio, a biologic medication used to treat inflammatory bowel disease, demonstrates the company's capability to supply specialized pharmaceutical products required by Department of Defense healthcare sites, reinforcing its established position as a preferred vendor for federal government medical supply procurement.
Quick answers
Who was awarded contract SPE2DX25F5ZVB?
SPE2DX25F5ZVB was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on April 21, 2025.
How much is contract SPE2DX25F5ZVB worth?
The government has obligated $49,449 on SPE2DX25F5ZVB.
Is contract SPE2DX25F5ZVB an order under another contract?
Yes. SPE2DX25F5ZVB is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F5ZVB competed?
The extent of competition for SPE2DX25F5ZVB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award